Shu He

1.4k total citations
42 papers, 1.1k citations indexed

About

Shu He is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shu He has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 17 papers in Pulmonary and Respiratory Medicine and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shu He's work include Blood Coagulation and Thrombosis Mechanisms (17 papers), Blood properties and coagulation (16 papers) and Platelet Disorders and Treatments (8 papers). Shu He is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (17 papers), Blood properties and coagulation (16 papers) and Platelet Disorders and Treatments (8 papers). Shu He collaborates with scholars based in Sweden, United States and Denmark. Shu He's co-authors include Margareta Blombäck, Katarina Bremme, Håkan Wallén, Ulla Hedner, Aleksandra Antovič, Niklas Bark, N. Håkan Wallén, Paul Hjemdahl, Jan Svensson and Nils Egberg and has published in prestigious journals such as Annals of the New York Academy of Sciences, Arteriosclerosis Thrombosis and Vascular Biology and British Journal of Haematology.

In The Last Decade

Shu He

42 papers receiving 1.1k citations

Peers

Countries citing papers authored by Shu He

Since Specialization

Citations

This map shows the geographic impact of Shu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu He more than expected).

Fields of papers citing papers by Shu He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu He. The network helps show where Shu He may publish in the future.

Co-authorship network of co-authors of Shu He

This figure shows the co-authorship network connecting the top 25 collaborators of Shu He. A scholar is included among the top collaborators of Shu He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu He. Shu He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of dabigatran, rivaroxaban, and apixaban on fibrin network permeability, thrombin generation, and fibrinolysis 2024 ·Scandinavian Journal of Clinical and Laboratory Investigation ·(unknown), Michał Ząbczyk, Shu He, Anna Ågren, Margareta Blombäck, (unknown), Mika Skeppholm	2
2	COVID-19: Not a thrombotic disease but a thromboinflammatory disease 2024 ·Upsala Journal of Medical Sciences ·Shu He, Margareta Blombäck, Håkan Wallén	2
3	A ROTEM method using APTT reagent and tissue factor as the clotting activators may better define bleeding heterogeneity in moderate or severe haemophilia A (part I: Study in plasma samples) 2018 ·Thrombosis Research ·Shu He, (unknown), Pia Petrini, Håkan Wallén, Lena Gabrielsson, Jan Svensson, Margareta Blombäck, Margareta Holmström	2
4	Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease 2015 ·Blood Coagulation & Fibrinolysis ·(unknown), Margareta Blombäck, (unknown), Shu He, Stefan H. Jacobson, Jonas Spaak	16
5	Correlation of ECR1 A3650G Polymorphism with Neonatal Respiratory Distress Syndrome 2014 ·Genetic Testing and Molecular Biomarkers ·Ying Dai, Qiwei Wang, Shu He, (unknown), Chao Gao	5
6	Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction 2012 ·Thrombosis and Haemostasis ·Karin Leander, Margareta Blombäck, Håkan Wallén, Shu He	32
7	Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate* 2011 ·British Journal of Haematology ·Margareta Blombäck, Shu He, Niklas Bark, Håkan Wallén, Margareta Elg	53
8	Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease 2011 ·Thrombosis and Haemostasis ·Fariborz Mobarrez, Shu He, Anders Bröijersén, (unknown), Aleksandra Antovič, Jovan P. Antović, Nils Egberg, Gun Jörneskog, Håkan Wallén	83
9	Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke 2010 ·Thrombosis Research ·(unknown), N. Håkan Wallén, Margareta Blombäck, Shu He	41
10	The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis 2010 ·Thrombosis and Haemostasis ·Margareta Blombäck, Niklas Bark, Hans Johnsson, N. Håkan Wallén, Shu He	46
11	Effects of Acetylsalicylic Acid on Increase of Fibrin Network Porosity and the Consequent Upregulation of Fibrinolysis 2009 ·Journal of Cardiovascular Pharmacology ·Shu He, Niklas Bark, Haiyao Wang, Jan Svensson, Margareta Blombäck	33
12	Modifications of flow measurement to determine fibrin gel permeability and the preliminary use in research and clinical materials 2005 ·Blood Coagulation & Fibrinolysis ·Shu He, (unknown), Aleksandra Antovič, (unknown)	30
13	Marked increase of fibrin gel permeability with very low dose ASA treatment 2005 ·Thrombosis Research ·Aleksandra Antovič, (unknown), (unknown), Håkan Wallén, Paul Hjemdahl, Margareta Blombäck, Shu He	41
14	Identifying hypocoagulable states with a modified global assay of overall haemostasis potential in plasma 2005 ·Blood Coagulation & Fibrinolysis ·Aleksandra Antovič, Margareta Blombäck, Margareta Sten-Linder, Pia Petrini, Margareta Holmström, Shu He	15
15	The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX 2003 ·Journal of Thrombosis and Haemostasis ·Shu He, Margareta Blombäck, (unknown), Ulla Hedner	116
16	The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism 2002 ·Blood Coagulation & Fibrinolysis ·Aleksandra Antovič, Margareta Blombäck, Katarina Bremme, Shu He	18
17	Hypercoagulation in surgical postmenopausal women having hormone replacement with overdose estradiol 2001 ·Blood Coagulation & Fibrinolysis ·Shu He, Katarina Bremme, Angela Silveira, M. van Rooijen, Margareta Blombäck	4
18	Are Increased Levels of von Willebrand Factor in Chronic Coronary Heart Disease Caused by Decrease in von Willebrand Factor Cleaving Protease Activity? 2001 ·Thrombosis Research ·Shu He, (unknown), Carl Magnusson, (unknown), (unknown), Karin Schenck‐Gustafsson, Margareta Blombäck	12
19	Can the laboratory assay of protein C activity assist in monitoring the hemostatic function in pre-eclampsia? 1999 ·Blood Coagulation & Fibrinolysis ·Shu He, Katarina Bremme, (unknown)	4
20	Increased blood flow resistance in placental circulation and levels of plasminogen activator inhibitors types 1 and 2 in severe preeclampsia 1995 ·Blood Coagulation & Fibrinolysis ·Shu He, Katarina Bremme, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact